CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Trinity Biotech plc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Trinity Biotech plc
IDA Business Park
Phone: +353 12769800p:+353 12769800 Bray, Wicklow  18  Ireland Fax: +353 12769888f:+353 12769888

This company is no longer actively traded on any major stock exchange.

Business Summary
Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Trinity Biotech also is a provider of raw materials to the life sciences and research industries globally. Trinity Biotech markets its portfolio of almost 850 products to customers in approximately 100 countries around the world. The primary market for Trinity Biotech's diagnostic products is the Americas (which consists principally of North America and South America). Its products are classified as point-of-care, emergency medicine, clinical laboratory and blood bank screening. The Company markets products under Uni-Gold, Recombigen, Meritas, Captia, MicroTrak, Bartels, MarDx, MarBlot, Premier, Ultra2, ImmuBlot, ImmuGlo, ImmuLisa, OTOblot and EZ.
(Source: 20-F)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201512/31/2013Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board RonanO'Caoimh 57 3/30/2011 1/1/1992
Chief Financial Officer, Secretary KevinTansley 42 11/1/2007 11/1/2007
Chief Operating Officer, Executive Director RoryNealon 45 11/8/2007 1/1/2003
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Trinity Biotech (UK) Ltd. 184 Cambridge Science Park Cambridge United Kingdom
CLARK LABORATORIES INC PO Box 1059 Jamestown New York United States
Trinity Biotech USA Inc. 2823 Girts Rd. Jamestown NY United States

Business Names
Business Name
Benen Trading Limited
Biopool AB
Biopool US Inc.
14 additional Business Names available in full report.

General Information
Number of Employees: 496 (As of 12/31/2013)
Outstanding Shares: 94,308,358 (As of 9/30/2015)
Shareholders: 527
Stock Exchange: ISE
Fax Number: +353 12769888


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023